toxin photo.jpg

Zeil Rosenberg, MD is Co-Founder and Clinical Advisor at Filament BioSolutions, a biopharmaceutical company developing and commercializing supportive care treatments for cancer patients such as for oral mucosititis and peripheral neuropathy. Previous to this he was Vice President, Medical Affairs at Admera Health, an advanced molecular diagnostics company focused on personalized medicine,  non-invasive cancer testing and direct -to-consumer genomic digital health products.  His expertise extends to vaccine, medical device and public health fields.

Dr. Rosenberg received his BA in Economics (awarded with Honors and Distinction) at Stanford, earned his MD at UCSF, completed his post-graduate medical training in Medicine and Preventive Medicine at Mt. Sinai and Cornell, respectively, and received  his MPH in Epidemiology at Columbia. He was selected to serve as AAAS Science, Engineering and Diplomacy Fellow at the US Agency for International Development.  Dr. Rosenberg is a Fellow of the American College of Preventive Medicine, Specialty Fellow of the American Academy of Pediatrics and Fellow of the New York Academy of Medicine. Dr Rosenberg was an adjunct faculty member at Columbia’s Mailman School of Public Health (1982-2017) where he advised start-up companies with high social impact potential.


View Zeil Rosenberg, M.D.'s profile on LinkedIn Find Zeil Rosenberg, M.D. on Google Plus